Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Ivan Diamond, MD, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentNeurology
    Phone510-527-0726
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      To contact Dr. Diamond please use the below information:

      Mailing Address:
      Senior Advisor
      Gilead Sciences
      333 Lakeside Dr
      Foster City CA 94404-1147
      Mobile: 510 914 2556
      Attention: Susan Edl, Assistant
      (650) 522-5602


      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Diamond I, Yao L. From Ancient Chinese Medicine to a Novel Approach to Treat Cocaine Addiction. CNS Neurol Disord Drug Targets. 2015; 14(6):716-26. PMID: 26022266.
        View in: PubMed
      2. Yao L, Fan P, Arolfo M, Jiang Z, Olive MF, Zablocki J, Sun HL, Chu N, Lee J, Kim HY, Leung K, Shryock J, Blackburn B, Diamond I. Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis. Nat Med. 2010 Sep; 16(9):1024-8. PMID: 20729865; PMCID: PMC3191463.
      3. Casey GP, Roberts JS, Paul D, Diamond I, Gould HJ. Ranolazine attenuation of CFA-induced mechanical hyperalgesia. Pain Med. 2010 Jan; 11(1):119-26. PMID: 20447295.
        View in: PubMed
      4. Gould HJ, Garrett C, Donahue RR, Paul D, Diamond I, Taylor BK. Ranolazine attenuates behavioral signs of neuropathic pain. Behav Pharmacol. 2009 Dec; 20(8):755-8. PMID: 19773645; PMCID: PMC2975014.
      5. Overstreet DH, Knapp DJ, Breese GR, Diamond I. A selective ALDH-2 inhibitor reduces anxiety in rats. Pharmacol Biochem Behav. 2009 Dec; 94(2):255-61. PMID: 19747934; PMCID: PMC2859712.
      6. Arolfo MP, Overstreet DH, Yao L, Fan P, Lawrence AJ, Tao G, Keung WM, Vallee BL, Olive MF, Gass JT, Rubin E, Anni H, Hodge CW, Besheer J, Zablocki J, Leung K, Blackburn BK, Lange LG, Diamond I. Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res. 2009 Nov; 33(11):1935-44. PMID: 19673742.
        View in: PubMed
      7. Fan P, Jiang Z, Diamond I, Yao L. Up-regulation of AGS3 during morphine withdrawal promotes cAMP superactivation via adenylyl cyclase 5 and 7 in rat nucleus accumbens/striatal neurons. Mol Pharmacol. 2009 Sep; 76(3):526-33. PMID: 19549762; PMCID: PMC2730385.
      8. Bowers MS, Hopf FW, Chou JK, Guillory AM, Chang SJ, Janak PH, Bonci A, Diamond I. Nucleus accumbens AGS3 expression drives ethanol seeking through G betagamma. Proc Natl Acad Sci U S A. 2008 Aug 26; 105(34):12533-8. PMID: 18719114; PMCID: PMC2527946.
      9. Yao L, Fan P, Jiang Z, Gordon A, Mochly-Rosen D, Diamond I. Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways. Mol Pharmacol. 2008 Apr; 73(4):1105-12. PMID: 18202306; PMCID: PMC2692587.
      10. Ferré S, Diamond I, Goldberg SR, Yao L, Hourani SM, Huang ZL, Urade Y, Kitchen I. Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol. 2007 Dec; 83(5):332-47. PMID: 17532111; PMCID: PMC2141681.
      11. Inoue Y, Yao L, Hopf FW, Fan P, Jiang Z, Bonci A, Diamond I. Nicotine and ethanol activate protein kinase A synergistically via G(i) betagamma subunits in nucleus accumbens/ventral tegmental cocultures: the role of dopamine D(1)/D(2) and adenosine A(2A) receptors. J Pharmacol Exp Ther. 2007 Jul; 322(1):23-9. PMID: 17468300.
        View in: PubMed
      12. Yang M, Soohoo D, Soelaiman S, Kalla R, Zablocki J, Chu N, Leung K, Yao L, Diamond I, Belardinelli L, Shryock JC. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists. Naunyn Schmiedebergs Arch Pharmacol. 2007 Apr; 375(2):133-44. PMID: 17310264.
        View in: PubMed
      13. Asyyed A, Storm D, Diamond I. Ethanol activates cAMP response element-mediated gene expression in select regions of the mouse brain. Brain Res. 2006 Aug 23; 1106(1):63-71. PMID: 16854384.
        View in: PubMed
      14. Yao L, McFarland K, Fan P, Jiang Z, Ueda T, Diamond I. Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc Natl Acad Sci U S A. 2006 May 16; 103(20):7877-82. PMID: 16684876; PMCID: PMC1458620.
      15. Yao L, McFarland K, Fan P, Jiang Z, Inoue Y, Diamond I. Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior. Proc Natl Acad Sci U S A. 2005 Jun 14; 102(24):8746-51. PMID: 15937104; PMCID: PMC1142483.
      16. Hopf FW, Mailliard WS, Gonzalez GF, Diamond I, Bonci A. Atypical protein kinase C is a novel mediator of dopamine-enhanced firing in nucleus accumbens neurons. J Neurosci. 2005 Jan 26; 25(4):985-9. PMID: 15673680.
        View in: PubMed
      17. Arolfo MP, Yao L, Gordon AS, Diamond I, Janak PH. Ethanol operant self-administration in rats is regulated by adenosine A2 receptors. Alcohol Clin Exp Res. 2004 Sep; 28(9):1308-16. PMID: 15365300.
        View in: PubMed
      18. Constantinescu A, Wu M, Asher O, Diamond I. cAMP-dependent protein kinase type I regulates ethanol-induced cAMP response element-mediated gene expression via activation of CREB-binding protein and inhibition of MAPK. J Biol Chem. 2004 Oct 8; 279(41):43321-9. PMID: 15299023.
        View in: PubMed
      19. Diamond I. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial. Alcohol Clin Exp Res. 2004 Aug; 28(8):1273. PMID: 15318128.
        View in: PubMed
      20. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bonci A, Messing RO. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci. 2004 Aug; 7(8):855-61. PMID: 15258586.
        View in: PubMed
      21. Souroujon MC, Yao L, Chen H, Endemann G, Khaner H, Geeraert V, Schechtman D, Gordon AS, Diamond I, Mochly-Rosen D. State-specific monoclonal antibodies identify an intermediate state in epsilon protein kinase C activation. J Biol Chem. 2004 Apr 23; 279(17):17617-24. PMID: 14761958.
        View in: PubMed
      22. Mailliard WS, Diamond I. Recent advances in the neurobiology of alcoholism: the role of adenosine. Pharmacol Ther. 2004 Jan; 101(1):39-46. PMID: 14729391.
        View in: PubMed
      23. Yao L, Fan P, Jiang Z, Mailliard WS, Gordon AS, Diamond I. Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14379-84. PMID: 14605213; PMCID: PMC283600.
      24. Hopf FW, Cascini MG, Gordon AS, Diamond I, Bonci A. Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. J Neurosci. 2003 Jun 15; 23(12):5079-87. PMID: 12832531.
        View in: PubMed
      25. Borenstein S, Diamond IR, Grant DR, Greig PD, Jones N, Ng V, Roberts E, Fecteau A. Outcome of pediatric live-donor liver transplantation-the Toronto experience. J Pediatr Surg. 2003 May; 38(5):668-71. PMID: 12720166.
        View in: PubMed
      26. Miyamae M, Domae N, Zhou HZ, Sugioka S, Diamond I, Figueredo VM. Phospholipase C activation is required for cardioprotection by ethanol consumption. Exp Clin Cardiol. 2003; 8(4):184-8. PMID: 19649218; PMCID: PMC2719158.
      27. Yao L, Arolfo MP, Dohrman DP, Jiang Z, Fan P, Fuchs S, Janak PH, Gordon AS, Diamond I. betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell. 2002 Jun 14; 109(6):733-43. PMID: 12086672.
        View in: PubMed
      28. Asher O, Cunningham TD, Yao L, Gordon AS, Diamond I. Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase. J Pharmacol Exp Ther. 2002 Apr; 301(1):66-70. PMID: 11907158.
        View in: PubMed
      29. Constantinescu A, Gordon AS, Diamond I. cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression: implications for neuronal responses to ethanol. J Biol Chem. 2002 May 24; 277(21):18810-6. PMID: 11886856.
        View in: PubMed
      30. Dohrman DP, Chen HM, Gordon AS, Diamond I. Ethanol-induced translocation of protein kinase A occurs in two phases: control by different molecular mechanisms. Alcohol Clin Exp Res. 2002 Mar; 26(3):407-15. PMID: 11923596.
        View in: PubMed
      31. Yao L, Asai K, Jiang Z, Ishii A, Fan P, Gordon AS, Diamond I. Dopamine D2 receptor inhibition of adenylyl cyclase is abolished by acute ethanol but restored after chronic ethanol exposure (tolerance). J Pharmacol Exp Ther. 2001 Aug; 298(2):833-9. PMID: 11454949.
        View in: PubMed
      32. Handa M, Choi DS, Caldeiro RM, Messing RO, Gordon AS, Diamond I. Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site. Gene. 2001 Jan 10; 262(1-2):301-7. PMID: 11179696.
        View in: PubMed
      33. Gordon AS, Yao L, Jiang Z, Fishburn CS, Fuchs S, Diamond I. Ethanol acts synergistically with a D2 dopamine agonist to cause translocation of protein kinase C. Mol Pharmacol. 2001 Jan; 59(1):153-60. PMID: 11125036.
        View in: PubMed
      34. Ron D, Vagts AJ, Dohrman DP, Yaka R, Jiang Z, Yao L, Crabbe J, Grisel JE, Diamond I. Uncoupling of betaIIPKC from its targeting protein RACK1 in response to ethanol in cultured cells and mouse brain. FASEB J. 2000 Nov; 14(14):2303-14. PMID: 11053252.
        View in: PubMed
      35. Choi DS, Handa M, Young H, Gordon AS, Diamond I, Messing RO. Genomic organization and expression of the mouse equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporter 1 (ENT1) gene. Biochem Biophys Res Commun. 2000 Oct 14; 277(1):200-8. PMID: 11027664.
        View in: PubMed
      36. Figueredo VM, Diamond I, Zhou HZ, Camacho SA. Chronic dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury. Am J Physiol. 1999 Nov; 277(5 Pt 2):H2091-7. PMID: 10564165.
        View in: PubMed
      37. Ron D, Jiang Z, Yao L, Vagts A, Diamond I, Gordon A. Coordinated movement of RACK1 with activated betaIIPKC. J Biol Chem. 1999 Sep 17; 274(38):27039-46. PMID: 10480917.
        View in: PubMed
      38. Constantinescu A, Diamond I, Gordon AS. Ethanol-induced translocation of cAMP-dependent protein kinase to the nucleus. Mechanism and functional consequences. J Biol Chem. 1999 Sep 17; 274(38):26985-91. PMID: 10480911.
        View in: PubMed
      39. Gordon AS, Yao L, Dohrman DP, Diamond I. Ethanol alters the subcellular localization of cAMP-dependent protein kinase and protein kinase C. Alcohol Clin Exp Res. 1998 Aug; 22(5 Suppl):238S-242S. PMID: 9727643.
        View in: PubMed
      40. Miyamae M, Rodriguez MM, Camacho SA, Diamond I, Mochly-Rosen D, Figueredo VM. Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci U S A. 1998 Jul 7; 95(14):8262-7. PMID: 9653175; PMCID: PMC20964.
      41. Miyamae M, Camacho SA, Zhou HZ, Diamond I, Figueredo VM. Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats. Am J Physiol. 1998 Jul; 275(1 Pt 2):H50-6. PMID: 9688895.
        View in: PubMed
      42. Asai K, Ishii A, Yao L, Diamond I, Gordon AS. Varying effects of ethanol on transfected cell lines. Alcohol Clin Exp Res. 1998 Feb; 22(1):163-6. PMID: 9514302.
        View in: PubMed
      43. Gordon AS, Yao L, Wu ZL, Coe IR, Diamond I. Ethanol alters the subcellular localization of delta- and epsilon protein kinase C in NG108-15 cells. Mol Pharmacol. 1997 Oct; 52(4):554-9. PMID: 9380017.
        View in: PubMed
      44. Miyamae M, Diamond I, Weiner MW, Camacho SA, Figueredo VM. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3235-9. PMID: 9096376; PMCID: PMC20352.
      45. Dohrman DP, Diamond I, Gordon AS. The role of the neuromodulator adenosine in alcohol's actions. Alcohol Health Res World. 1997; 21(2):136-43. PMID: 15704350.
        View in: PubMed
      46. Diamond I, Gordon AS. Cellular and molecular neuroscience of alcoholism. Physiol Rev. 1997 Jan; 77(1):1-20. PMID: 9016298.
        View in: PubMed
      47. Coe IR, Yao L, Diamond I, Gordon AS. The role of protein kinase C in cellular tolerance to ethanol. J Biol Chem. 1996 Nov 15; 271(46):29468-72. PMID: 8910614.
        View in: PubMed
      48. Dohrman DP, Diamond I, Gordon AS. Ethanol causes translocation of cAMP-dependent protein kinase catalytic subunit to the nucleus. Proc Natl Acad Sci U S A. 1996 Sep 17; 93(19):10217-21. PMID: 8816779; PMCID: PMC38364.
      49. Coe IR, Dohrman DP, Constantinescu A, Diamond I, Gordon AS. Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol. J Pharmacol Exp Ther. 1996 Feb; 276(2):365-9. PMID: 8632298.
        View in: PubMed
      50. Sapru MK, Diamond I, Gordon AS. Adenosine receptors mediate cellular adaptation to ethanol in NG108-15 cells. J Pharmacol Exp Ther. 1994 Oct; 271(1):542-8. PMID: 7965754.
        View in: PubMed
      51. Diamond I, Messing RO. Neurologic effects of alcoholism. West J Med. 1994 Sep; 161(3):279-87. PMID: 7975567; PMCID: PMC1011410.
      52. Krauss SW, Diamond I, Gordon AS. Selective inhibition by ethanol of the type 1 facilitative glucose transporter (GLUT1). Mol Pharmacol. 1994 Jun; 45(6):1281-6. PMID: 8022421.
        View in: PubMed
      53. Diamond I, Gordon AS. The role of adenosine in mediating cellular and molecular responses to ethanol. EXS. 1994; 71:175-83. PMID: 8032148.
        View in: PubMed
      54. Krauss SW, Ghirnikar RB, Diamond I, Gordon AS. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters. Mol Pharmacol. 1993 Nov; 44(5):1021-6. PMID: 7902530.
        View in: PubMed
      55. Gordon AS, Diamond I. Adenosine mediates the effects of ethanol on the cAMP signal transduction system. Alcohol Alcohol Suppl. 1993; 2:437-41. PMID: 7748335.
        View in: PubMed
      56. Nagy LE, Diamond I, Gordon AS. cAMP-dependent protein kinase regulates inhibition of adenosine transport by ethanol. Mol Pharmacol. 1991 Nov; 40(5):812-7. PMID: 1658611.
        View in: PubMed
      57. Diamond I, Nagy L, Mochly-Rosen D, Gordon A. The role of adenosine and adenosine transport in ethanol-induced cellular tolerance and dependence. Possible biologic and genetic markers of alcoholism. Ann N Y Acad Sci. 1991; 625:473-87. PMID: 2058901.
        View in: PubMed
      58. Gordon AS, Krauss SW, Nagy L, Diamond I. Nucleoside transport in lymphocytes from alcoholics and non-alcoholics. Adv Exp Med Biol. 1991; 309A:387-90. PMID: 1665009.
        View in: PubMed
      59. Nagy LE, Diamond I, Casso DJ, Franklin C, Gordon AS. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem. 1990 Feb 5; 265(4):1946-51. PMID: 2298733.
        View in: PubMed
      60. Gordon AS, Nagy L, Mochly-Rosen D, Diamond I. Chronic ethanol-induced heterologous desensitization is mediated by changes in adenosine transport. Biochem Soc Symp. 1990; 56:117-36. PMID: 2175189.
        View in: PubMed
      61. Nagy LE, Diamond I, Collier K, Lopez L, Ullman B, Gordon AS. Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol. 1989 Nov; 36(5):744-8. PMID: 2555672.
        View in: PubMed
      62. Diamond I. Alcoholic myopathy and cardiomyopathy. N Engl J Med. 1989 Feb 16; 320(7):458-60. PMID: 2913510.
        View in: PubMed
      63. Nagy LE, Diamond I, Gordon A. Cultured lymphocytes from alcoholic subjects have altered cAMP signal transduction. Proc Natl Acad Sci U S A. 1988 Sep; 85(18):6973-6. PMID: 2842798; PMCID: PMC282101.
      64. Mochly-Rosen D, Chang FH, Cheever L, Kim M, Diamond I, Gordon AS. Chronic ethanol causes heterologous desensitization of receptors by reducing alpha s messenger RNA. Nature. 1988 Jun 30; 333(6176):848-50. PMID: 2838757.
        View in: PubMed
      65. Diamond I. Studies of acute and chronic effects of ethanol on early evoked potentials. Alcohol. 1987 Jul-Aug; 4(4):255-6. PMID: 3620093.
        View in: PubMed
      66. Diamond I, Wrubel B, Estrin W, Gordon A. Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients. Proc Natl Acad Sci U S A. 1987 Mar; 84(5):1413-6. PMID: 3029780; PMCID: PMC304440.
      67. Gordon AS, Wrubel B, Collier K, Estrin W, Diamond I. Adaptation to ethanol in cultured neural cells and human lymphocytes from alcoholics. Ann N Y Acad Sci. 1987; 492:367-74. PMID: 3037965.
        View in: PubMed
      68. Messing RO, Carpenter CL, Diamond I, Greenberg DA. Ethanol regulates calcium channels in clonal neural cells. Proc Natl Acad Sci U S A. 1986 Aug; 83(16):6213-5. PMID: 2426713; PMCID: PMC386470.
      69. Gordon AS, Collier K, Diamond I. Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. Proc Natl Acad Sci U S A. 1986 Apr; 83(7):2105-8. PMID: 3008152; PMCID: PMC323239.
      70. Charness ME, Querimit LA, Diamond I. Ethanol increases the expression of functional delta-opioid receptors in neuroblastoma x glioma NG108-15 hybrid cells. J Biol Chem. 1986 Mar 5; 261(7):3164-9. PMID: 3005282.
        View in: PubMed
      71. Gordon AS, Diamond I. Phosphorylation of the nicotinic acetylcholine receptor. Prog Brain Res. 1986; 69:141-7. PMID: 3447229.
        View in: PubMed
      72. Magilen G, Ziskind-Conhaim L, Diamond I, Gordon AS. Irreversible inhibition of phospholipid methylation and protein carboxymethylation does not alter acetylcholine receptor function in muscle cells. Exp Neurol. 1984 Nov; 86(2):198-207. PMID: 6489494.
        View in: PubMed
      73. Greenberg DA, Cooper EC, Gordon A, Diamond I. Ethanol and the gamma-aminobutyric acid-benzodiazepine receptor complex. J Neurochem. 1984 Apr; 42(4):1062-8. PMID: 6321657.
        View in: PubMed
      74. Lo W, Packman S, Nash S, Schmidt K, Ireland S, Diamond I, Ng W, Donnell G. Curious neurologic sequelae in galactosemia. Pediatrics. 1984 Mar; 73(3):309-12. PMID: 6701054.
        View in: PubMed
      75. Charness ME, Gordon AS, Diamond I. Interaction of ethanol with neural cells in culture: a model of intoxication, tolerance and withdrawal. Ciba Found Symp. 1984; 105:73-84. PMID: 6563992.
        View in: PubMed
      76. Charness ME, Gordon AS, Diamond I. Ethanol modulation of opiate receptors in cultured neural cells. Science. 1983 Dec 16; 222(4629):1246-8. PMID: 6316506.
        View in: PubMed
      77. Gordon AS, Milfay D, Diamond I. Identification of a molecular weight 43,000 protein kinase in acetylcholine receptor-enriched membranes. Proc Natl Acad Sci U S A. 1983 Oct; 80(19):5862-5. PMID: 6577458; PMCID: PMC390175.
      78. Koch TK, Gordon AS, Diamond I. Phospholipid methylation in myogenic cells. Biochem Biophys Res Commun. 1983 Jul 18; 114(1):339-47. PMID: 6882429.
        View in: PubMed
      79. Davis CG, Hestrin S, Landahl H, Gordon AS, Diamond I, Korenbrot JI. Activation of acetylcholine receptors causes the partition of hydrophobic cations into postsynaptic membrane vesicles. Nature. 1983 Apr 7; 302(5908):525-8. PMID: 6835384.
        View in: PubMed
      80. Davis CG, Gordon AS, Diamond I. Specificity and localization of the acetylcholine receptor kinase. Proc Natl Acad Sci U S A. 1982 Jun; 79(11):3666-70. PMID: 6954509; PMCID: PMC346484.
      81. Magilen G, Gordon A, Au A, Diamond I. Identification of a mitochondrial phosphoprotein in brain synaptic membrane preparations. J Neurochem. 1981 May; 36(5):1861-4. PMID: 6787174.
        View in: PubMed
      82. Thomas RA, Gordon AS, Diamond I. Phosphoprotein phosphatase activity in normal and dystonic human fibroblast plasma membranes. Proc Soc Exp Biol Med. 1981 Mar; 166(3):405-12. PMID: 6259646.
        View in: PubMed
      83. Gordon AS, Davis CG, Milfay D, Kaur J, Diamond I. Membrane-bound protein kinase activity in acetylcholine receptor-enriched membranes. Biochim Biophys Acta. 1980 Aug 4; 600(2):421-31. PMID: 6250598.
        View in: PubMed
      84. Gordon AS, Diamond I. Regulation of acetylcholine receptor phosphorylation. Adv Biochem Psychopharmacol. 1980; 21:117-24. PMID: 6246736.
        View in: PubMed
      85. Gordon AS, Diamond I. Reversible phosphorylation of the membrane-bound acetylcholine receptor. J Supramol Struct. 1980; 14(2):163-74. PMID: 6262575.
        View in: PubMed
      86. Gordon AS, Guillory RJ, Diamond I, Hucho F. ATP-binding proteins in acetylcholine receptor-enriched membranes. FEBS Lett. 1979 Dec 1; 108(1):37-9. PMID: 520560.
        View in: PubMed
      87. Schmidley J, Sander J, Diamond I, Fishman RA. Dangers of mannitol in treatment of Reye's syndrome. N Engl J Med. 1979 Jul 12; 301(2):106-7. PMID: 449934.
        View in: PubMed
      88. Gordon AS, Milfay D, Davis CG, Diamond I. Protein phosphatase activity in acetylcholine receptor-enriched membranes. Biochem Biophys Res Commun. 1979 Apr 13; 87(3):876-83. PMID: 36894.
        View in: PubMed
      89. Gordon AS, Milfay D, Diamond I. Phosphorylation of the membrane-bound acetylcholine receptor: inhibition by diphenylhydantoin. Ann Neurol. 1979 Feb; 5(2):201-3. PMID: 426485.
        View in: PubMed
      90. Gordon AS, Diamond I. Phosphorylation of the acetylcholine receptor. Adv Exp Med Biol. 1979; 116:175-98. PMID: 224669.
        View in: PubMed
      91. Bornstein JC, Pickett JB, Diamond I. Inhibition of the evoked release of acetylcholine by the porphyrin precursor delta-aminolevulinic acid. Ann Neurol. 1979 Jan; 5(1):94-6. PMID: 218495.
        View in: PubMed
      92. Schneider JA, Diamond I, Rozengurt E. Glycolysis of quiescent cultures of 3T3 cells. Addition of serum, epidermal growth factor, and insulin increases the activity of phosphofructokinase in a protein synthesis-independent manner. J Biol Chem. 1978 Feb 10; 253(3):872-7. PMID: 146038.
        View in: PubMed
      93. Diamond I, Legg A, Schneider JA, Rozengurt E. Glycolysis in quiescent cultures of 3T3 cells. Stimulation by serum, epidermal growth factor, and insulin in intact cells and persistence of the stimulation after cell homogenization. J Biol Chem. 1978 Feb 10; 253(3):866-71. PMID: 304448.
        View in: PubMed
      94. Rozengurt E, Schneider JA, Diamond I, Legg A. The high rate of aerobic glycolysis of transformed 3T3 cells persists after cell homogenization. Biochem Biophys Res Commun. 1977 Sep 9; 78(1):83-90. PMID: 199175.
        View in: PubMed
      95. Gordon AS, Davis CG, Milfay D, Diamond I. Phosphorylation of acetylcholine receptor by endogenous membrane protein kinase in receptor-enriched membranes of Torpedo californica. Nature. 1977 Jun 9; 267(5611):539-40. PMID: 876372.
        View in: PubMed
      96. Simon K, Chaplin ER, Diamond I. Separation of lactate dehydrogenase isoenzymes in rat brain by acrylamide--gel electrophoresis. Anal Biochem. 1977 May 1; 79(1-2):571-4. PMID: 869193.
        View in: PubMed
      97. Goldstein GW, Csejtey J, Diamond I. Carrier mediated glucose transport in capillaries isolated from rat brain. J Neurochem. 1977 Apr; 28(4):725-8. PMID: 894281.
        View in: PubMed
      98. Diamond I, Granelli SG, McDonagh AF. Photochemotherapy and photodynamic toxicity: simple methods for identifying potentially active agents. Biochem Med. 1977 Apr; 17(2):121-7. PMID: 558753.
        View in: PubMed
      99. Gordon AS, Davis CG, Diamond I. Phosphorylation of membrane proteins at a cholinergic synapse. Proc Natl Acad Sci U S A. 1977 Jan; 74(1):263-7. PMID: 264679; PMCID: PMC393239.
      100. Chaplin ER, Goldberg AL, Diamond I. Leucine oxidation in brain slices and nerve endings. J Neurochem. 1976 Apr; 26(4):701-7. PMID: 965962.
        View in: PubMed
      101. Goldstein GW, Wolinsky JS, Csejtey J, Diamond I. Isolation of metabolically active capillaries from rat brain. J Neurochem. 1975 Nov; 25(5):715-7. PMID: 1194927.
        View in: PubMed
      102. Openshaw H, Diamond I. Extraction of D-beta-hydroxybutyrate by brain in diabetic rats. Arch Neurol. 1975 Sep; 32(9):640-1. PMID: 126053.
        View in: PubMed
      103. Granelli SG, Diamond I, McDonagh AF, Wilson CB, Nielsen SL. Photochemotherapy of glioma cells by visible light and hematoporphyrin. Cancer Res. 1975 Sep; 35(9):2567-70. PMID: 1149051.
        View in: PubMed
      104. Griffiths WC, Diamond I, Dextraze P. The albumin binding of unconjugated bilirubin in serum. Clin Biochem. 1975 Aug; 8(4):254-60. PMID: 1157293.
        View in: PubMed
      105. Diamond I, Granelli SG, McDonagh SF, Crafts D, Wilson CB. Photodynamic therapy of experimental gliomas. Trans Am Neurol Assoc. 1975; 100:185-7. PMID: 1226605.
        View in: PubMed
      106. Goldstein GW, Asbury AK, Diamond I. Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch Neurol. 1974 Dec; 31(6):382-9. PMID: 4216346.
        View in: PubMed
      107. Diamond I, Franklin GM, Milfay D. The relationship of choline acetyltransferase activity at the neuromuscular junction to changes in muscle mass and function. J Physiol. 1974 Jan; 236(1):247-57. PMID: 4818500; PMCID: PMC1350837.
      108. Goldstein GW, Diamond I. Metabolic basis of lead encephalopathy. Res Publ Assoc Res Nerv Ment Dis. 1974; 53:293-304. PMID: 4280106.
        View in: PubMed
      109. Diamond I, Fishman RA. Development of Na+-stimulated glucose oxidation in synaptosomes. J Neurochem. 1973 Nov; 21(5):1043-50. PMID: 4761694.
        View in: PubMed
      110. Diamond I, Fishman RA. Preferential phosphorylation of recently transported 2-deoxy-D-glucose in isolated nerve endings. Brain Res. 1973 Jul 16; 57(1):239-43. PMID: 4716757.
        View in: PubMed
      111. Diamond I, Fishman RA. Development of glucose oxidation in isolated nerve endings. Nature. 1973 Jun 29; 243(5409):519-20. PMID: 4270335.
        View in: PubMed
      112. Diamond I, Fishman RA. High-affinity transport and phosphorylation of 2-deoxy-D-glucose in synaptosomes. J Neurochem. 1973 Jun; 20(6):1533-42. PMID: 4719311.
        View in: PubMed
      113. Diamond I, Granelli SG, McDonagh AF, Nielsen S, Wilson CB, Jaenicke R. Photodynamic therapy of malignant tumours. Lancet. 1972 Dec 2; 2(7788):1175-7. PMID: 4117595.
        View in: PubMed
      114. Yatsu FM, Diamond I, Graziano C, Lindquist P. Experimental brain ischemia: protection from irreversible damage with a rapid-acting barbiturate (methohexital). Stroke. 1972 Nov-Dec; 3(6):726-32. PMID: 4639103.
        View in: PubMed
      115. Roost KT, Pimstone NR, Diamond I, Schmid R. The formation of cerebrospinal fluid xanthochromia after subarachnoid hemorrhage. Enzymatic conversion of hemoglobin to bilirubin by the arachnoid and choroid plexus. Neurology. 1972 Sep; 22(9):973-7. PMID: 4673383.
        View in: PubMed
      116. Diamond I, Milfay D. Uptake of ( 3 H-methyl)choline by microsomal, synaptosomal, mitochondrial and synaptic vesicle fractions of rat brain. The effects of hemicholinium. J Neurochem. 1972 Aug; 19(8):1899-909. PMID: 5047852.
        View in: PubMed
      117. Diamond I, Goldberg AL. Uptake and release of 45Ca by brain microsomes, synaptosomes and synaptic vesicles. J Neurochem. 1971 Aug; 18(8):1419-31. PMID: 4328512.
        View in: PubMed
      118. Diamond I. Choline metabolism in brain. The role of choline transport and the effects of phenobarbital. Arch Neurol. 1971 Apr; 24(4):333-9. PMID: 5548453.
        View in: PubMed
      119. Diamond IF. Studies on the neurotoxicity of bilirubin and the distribution of its derivatives. Birth Defects Orig Artic Ser. 1970 Jun; 6(2):124-7. PMID: 5535456.
        View in: PubMed
      120. Diamond I. Choline metabolism in the central nervous system: the role of choline transport from plasma to brain. Neurology. 1970 Apr; 20(4):382. PMID: 5534994.
        View in: PubMed
      121. Diamond I, Kennedy EP. Carrier-mediated transport of choline into synaptic nerve endings. J Biol Chem. 1969 Jun 25; 244(12):3258-63. PMID: 5797515.
        View in: PubMed
      122. Diamond I. Bilirubin binding and kernicterus. Adv Pediatr. 1969; 16:99-119. PMID: 4899063.
        View in: PubMed
      123. Diamond I, Kennedy EP. A sensitive radiochemical assay for choline acetylase. Anal Biochem. 1968 Jul; 24(1):90-5. PMID: 5665202.
        View in: PubMed
      124. Diamond I, Schmid R. Neonatal hyperbilirubinemia and kernicterus. Experimental support for treatment by exposure to visible light. Arch Neurol. 1968 Jun; 18(6):699-702. PMID: 5690104.
        View in: PubMed
      125. Diamond I, Lucey J, Schmid R. Prevention of hyperbilirubinemia and kernicterus by exposure to light: studies in newborn guinea pigs and premature infants. Trans Am Neurol Assoc. 1968; 93:70-4. PMID: 5711055.
        View in: PubMed
      126. Diamond I, Schmid R. Oxidative phosphorylation in experimental bilirubin encephalopathy. Science. 1967 Mar 10; 155(3767):1288-9. PMID: 6018655.
        View in: PubMed
      127. Diamond I, Odell GB, Johnson L, Boggs TR, Lucey JF. Kernicterus: revised concepts of pathogenesis and management. Pediatrics. 1966 Oct; 38(4):539-46. PMID: 5922172.
        View in: PubMed
      128. Diamond I, Schmid R. Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system. J Clin Invest. 1966 May; 45(5):678-89. PMID: 5949114; PMCID: PMC292745.
      129. Diamond I. Bilirubin encephalopathy: experimental models in newborn and adult animals. Proc Inst Med Chic. 1966 May; 26(3):47-8. PMID: 5936505.
        View in: PubMed
      130. Schmid R, Diamond I, Hammaker L, Gundersen CB. Interaction of bilirubin with albumin. Nature. 1965 Jun 5; 206(988):1041-3. PMID: 5839057.
        View in: PubMed
      131. DIAMOND I, AQUINO TI. MYOGLOBINURIA FOLLOWING UNILATERAL STATUS EPILEPTICUS AND IPSILATERAL RHABDOMYOLYSIS: A CLINICOPATHOLOGICAL REPORT. N Engl J Med. 1965 Apr 22; 272:834-7. PMID: 14267988.
        View in: PubMed
      132. Diamond I, Schmid R. The pathogenesis of bilirubin encephalopathy: experimental models in newborn and adult animals. Trans Am Neurol Assoc. 1965; 90:38-41. PMID: 5857773.
        View in: PubMed
      Ivan's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP